CDKN2D Antikörper
Kurzübersicht für CDKN2D Antikörper (ABIN1106659)
Target
Alle CDKN2D Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- This antibody recognizes Human p19INK4d and shows no cross reactivity with other proteins.
-
Aufreinigung
- Affinity chromatography
-
Immunogen
- Recombinant human p19INK4d.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Rekonstitution
- Restore with 1.2 % Sodium Acetate or neutral PBS
-
Konzentration
- 0,1 mg/mL
-
Buffer
- 1.2 % Sodium Acetate, 0.01 mg Sodium Azide, 2 mg BSA
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Prior to reconstitution store at -20 °C. Following reconstitution store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- CDKN2D (Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) (CDKN2D))
-
Andere Bezeichnung
- CDKN2D / p19INK4d
-
Hintergrund
- Cyclins are important in regulating the cell cycle through their formation of enzymatic complexes with various cyclin-dependent kinases. P19(INK4d) also kowns as cyclin-dependent kinase inhibitor 2D, is one of the novel members of the mouse INK4 gene family. Okuda et al. (1995) described the cloning of the human INK4d gene (CDKN2D). The predicted 166-amino acid protein is 86 % identical to the mouse protein and about 45 % identical to other human INK4 family members.Synonyms: Cyclin-dependent kinase 4 inhibitor D, INK4D, p19, p19-INK4d
-
Gen-ID
- 1032
-
NCBI Accession
- NP_001791
-
UniProt
- P55273
-
Pathways
- Zellzyklus, Sensory Perception of Sound, Mitotic G1-G1/S Phases, Negative Regulation of intrinsic apoptotic Signaling
Target
-